Health informatics

Improved air leak detection reduces chest tube duration: Study

An initiative at a Texas hospital contributed to reductions in chest tube duration, hospital length of stay and readmissions for patients with lung cancer who had a pulmonary lobectomy, according to new research published ...

Inflammatory disorders

FDA approves Wezlana for multiple inflammatory diseases

The U.S. Food and Drug Administration has approved Amgen's Wezlana (ustekinumab-auub) as a biosimilar to and interchangeable with Stelara (ustekinumab) for multiple inflammatory diseases.

page 5 from 40